Brief: RaQualia Pharma says sodium channel blocker patent allowance in China
25/07/2016 07:12
July 25 (Reuters) - RaQualia Pharma Inc 4579.T :
* Says the company received an allowance for a sodium
channel blocker substance patent in China (Application Number:
201180050306.2, Arylamide derivatives)
Source text in Japanese: https://goo.gl/9WQlcA
Further company Coverage: 4579.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))